[HTML][HTML] Epigenetic modulation of antitumor immunity for improved cancer immunotherapy

E Dai, Z Zhu, S Wahed, Z Qu, WJ Storkus, ZS Guo - Molecular cancer, 2021 - Springer
Epigenetic mechanisms play vital roles not only in cancer initiation and progression, but also
in the activation, differentiation and effector function (s) of immune cells. In this review, we …

[HTML][HTML] Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy

Y Lu, YT Chan, HY Tan, S Li, N Wang, Y Feng - Molecular cancer, 2020 - Springer
Epigenetics is dynamic and heritable modifications to the genome that occur independently
of DNA sequence. It requires interactions cohesively with various enzymes and other …

Immune checkpoints in the tumor microenvironment

SM Toor, VS Nair, J Decock, E Elkord - Seminars in cancer biology, 2020 - Elsevier
Interactions between immune checkpoints (ICs) and their ligands negatively regulate T cell
activation pathways involved in physiological immune responses against specific antigens …

[HTML][HTML] The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers

Q Tang, Y Chen, X Li, S Long, Y Shi, Y Yu… - Frontiers in …, 2022 - frontiersin.org
Programmed cell death protein-1 (PD-1) is a checkpoint receptor expressed on the surface
of various immune cells. PD-L1, the natural receptor for PD-1, is mainly expressed in tumor …

[HTML][HTML] Colorectal cancer-infiltrating regulatory T cells: functional heterogeneity, metabolic adaptation, and therapeutic targeting

S Aristin Revilla, O Kranenburg, PJ Coffer - Frontiers in immunology, 2022 - frontiersin.org
Colorectal cancer (CRC) is a heterogeneous disease with one of the highest rates of
incidence and mortality among cancers worldwide. Understanding the CRC tumor …

[HTML][HTML] Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer

R Saleh, RZ Taha, SM Toor, V Sasidharan Nair… - Cancer Immunology …, 2020 - Springer
Despite recent advances in colorectal cancer (CRC) treatment, a large proportion of patients
show limited responses to therapies, especially in advanced stages. There is an urgent …

[HTML][HTML] Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer

X Zhu, R Liang, T Lan, D Ding, S Huang… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Onco-immunogenic molecule CD155 is overexpressed in various tumor
microenvironments (TME) including in colorectal cancer (CRC). Tumor-associated …

Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer

BL Li, XP Wan - Journal of Cellular and Molecular Medicine, 2020 - Wiley Online Library
Tumour microenvironment (TME) is crucial to tumorigenesis. This study aimed to uncover
the differences in immune phenotypes of TME in endometrial cancer (EC) using Uterine …

Immunogenic cell death in colon cancer prevention and therapy

H Ruan, BJ Leibowitz, L Zhang… - Molecular carcinogenesis, 2020 - Wiley Online Library
Colorectal cancer (CRC) is a leading cause of cancer‐related death worldwide. The colonic
mucosa constitutes a critical barrier and a major site of immune regulation. The immune …

[HTML][HTML] Methylation across the central dogma in health and diseases: new therapeutic strategies

R Liu, E Zhao, H Yu, C Yuan, MN Abbas… - Signal Transduction and …, 2023 - nature.com
The proper transfer of genetic information from DNA to RNA to protein is essential for cell-
fate control, development, and health. Methylation of DNA, RNAs, histones, and non-histone …